0001437749-22-019862.txt : 20220810
0001437749-22-019862.hdr.sgml : 20220810
20220810180851
ACCESSION NUMBER: 0001437749-22-019862
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220808
FILED AS OF DATE: 20220810
DATE AS OF CHANGE: 20220810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Furlow Brenda S.
CENTRAL INDEX KEY: 0001443851
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 221153041
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-08-08
0000842023
BIO-TECHNE Corp
TECH
0001443851
Furlow Brenda S.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
1
SVP - General Counsel
Common Stock
2022-08-08
4
M
0
563
177.32
A
6523
D
Common Stock
1330
I
By Trust #1
Common Stock
1330
I
By Trust #2
Stock Options (Right to Buy)
125.0500
2024-08-09
Common Stock
9503
9503
D
Stock Options (Right to Buy)
177.32
2022-08-08
4
M
0
563
0
D
2025-08-08
Common Stock
563
16562
D
Stock Options (Right to Buy)
190.4100
2026-08-07
Common Stock
9968
9968
D
Stock Options (Right to Buy)
190.4100
2026-08-07
Common Stock
13290
13290
D
Restricted Stock Units
Common Stock
1679
1679
D
Stock Options (Right to Buy)
267.8700
2027-08-05
Common Stock
7492
7492
D
Stock Options (Right to Buy)
267.8700
2027-08-05
Common Stock
9990
9990
D
Stock Options (Right to Buy)
267.8700
2027-08-05
Common Stock
8325
8325
D
Stock Options (Right to Buy)
267.8700
2027-08-05
Common Stock
8325
8325
D
Stock Options (Right to Buy)
372.4400
2022-08-31
2028-03-01
Common Stock
10997
10997
D
Restricted Stock Units
Common Stock
1167
1167
D
Stock Options (Right to Buy)
481.8200
2028-08-06
Common Stock
4560
4560
D
Stock Options (Right to Buy)
481.8200
2028-08-06
Common Stock
6080
6080
D
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Fully exercisable.
On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs.
Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
/s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed.
2022-08-10